Dr Khaled Al-Shaibi and Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, SB) joined us to discuss the top 5 late-breaking interventional cardiology highlights of ACC.
In this discussion, interventional experts delve into the latest research, findings and considerations for practice from trials, including:
0:29: The RENOVATE-COMPLEX-PCI Trial
6:22: The BIOVASC Trial
7:11: TRILUMINATE Trial
10:30: The COAPT Trial
13:17: The Evolut Low Risk Trial
For more content from ACC.23/WCC and the Late-breaker Discussion series head to Late-Breaking Science Video Collection.
Recorded on-site at ACC.23, New Orleans.
Visit Radcliffe Cardiology:
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook:
Follow us on Twitter: